COGT
COGT
NASDAQ · Biotechnology

Cogent Biosciences Inc

$31.50
-1.69 (-5.09%)
Analyst Consensus
Strong Buy
18
Analysts
High
Coverage
Buy 16 89%
Hold 2 11%
Sell 0 0%
Price Target
Analyst Price Target +166.6% upside
Low Target $51.90
Average Target $83.97
High Target $108.57
Current Price $31.50
Current
$31.50
Target
$83.97
$51.90 $83.97 avg $108.57
Scenario Analysis
Bear Case
$51.90
64.8%
Low target
Base Case
$83.97
+166.6%
Avg target
Bull Case
$108.57
+244.7%
High target
Risk/Reward
3.8x
Highly favorable
Price in Context
52-Week High
$43.73
-28.0% from high
52-Week Low
$11.60
+171.6% from low
50-Day SMA
$37.85
-16.8% vs SMA
200-Day SMA
$20.09
+56.8% vs SMA
RSI (14)
53.0
Neutral
Target vs 52W High
$83.97
+92.0% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 39 82% $257.58 -2.4%
AMGN
Amgen Inc
Hold 43 47% $190.87 -50.5%
GILD
Gilead Sciences Inc
Strong Buy 37 81% $362.68 +141.6%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 36 81% $438.34 -13.8%
REGN
Regeneron Pharmaceuticals
Buy 38 68% $76.80 -90.2%
MRNA
Moderna Inc
Hold 30 37% $149.45 -3.0%
NTRA
Natera Inc
Strong Buy 30 87% $142.91 -61.3%
RVMD
Revolution Medicines Inc
Strong Buy 28 93% $114.11 -40.2%